新生儿静脉注射对比剂对血清肌酐水平的影响
回顾性匹配队列研究纳入140例接受含碘或含钆对比剂的新生儿,与性别、胎龄、日龄及基线血清肌酐匹配的未增强检查组比较,各时间点血清肌酐和GFR无显著差异,高肌酐比例及肾毒性风险未见增加,未发生肾源性系统性纤维化。
要点
- 新生儿静脉注射碘对比剂或钆对比剂后各时间点血清肌酐与未增强组相似。
- 两组血清肌酐高于参考范围(>0.4 mg/dL)的比例无显著差异。
- 在无已知肾衰竭的新生儿中未观察到对比剂相关肾毒性增加。
核心结论
- 在无已知肾衰竭的新生儿中,接受标准住院治疗时静脉注射碘对比剂或钆对比剂似乎不会增加肾毒性风险。
研究设计与样本
- 经机构审查委员会批准并豁免知情同意的回顾性电子健康记录审查,2011年1月至2013年4月纳入140例接受对比剂的住院新生儿(CT碘对比剂59例,MR钆对比剂81例),按性别、胎龄、日龄及基线血清肌酐与未增强检查组频率匹配。
诊断标准与关键数值
- 血清肌酐参考范围上限为>0.4 mg/dL;CT组与MR组各时间点血清肌酐及GFR与未增强组相似(CT组P≤.01、MR组P≤.01为组内前后变化);碘对比剂组高肌酐比例P>.12,钆对比剂组P>.13。
临床应用与阅片要点
- 新生儿静脉注射碘对比剂或钆对比剂后,可参照本研究的各时间点血清肌酐和GFR变化评估肾功能,无需因对比剂而额外担忧肾毒性;本研究未发生肾源性系统性纤维化。
局限性
- 本研究为回顾性研究。
- 本研究为单中心研究。
- 本研究样本量有限(共140例)。
- 本研究仅纳入无已知肾衰竭的新生儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess the effect of intravenous contrast media on renal function in neonates. Materials and Methods Institutional review board approval was obtained with waiver of consent. Electronic health records from January 2011 to April 2013 were reviewed retrospectively. Measures of renal function were obtained in inpatient neonates who underwent magnetic resonance (MR) imaging or computed tomography (CT) and for whom serum creatinine (Cr) levels were obtained within 72 hours before imaging and at least one time after imaging (>1 day after administration of contrast material). A total of 140 neonates who received contrast material (59 who underwent CT with iohexol or iodixanol and 81 who underwent MR imaging with gadopentetate dimeglumine) were identified. These neonates were frequency matched according to sex, gestational and postnatal age, and preimaging serum Cr levels with neonates who underwent unenhanced MR imaging or CT. Cr levels and glomerular filtration rates (GFRs) were grouped according to when they were obtained (before imaging, 1-2 days after imaging, 3-5 days after imaging, 6-9 days after imaging, 10-45 days after imaging, and more than 45 days after imaging). Serum Cr levels and GFRs for each time period were compared between groups by using hierarchic regressions or χ2 or Fisher exact tests and with repeated-measures analysis of variance to compare groups on the rate of change in serum Cr levels and GFRs from before to after imaging. Results Cr levels decreased and GFRs increased in both groups from before to after imaging (CT group, P ≤ .01; MR imaging group, P ≤ .01). The neonates who underwent contrast material-enhanced imaging and the neonates who underwent unenhanced imaging showed similar serum Cr levels at all examined time periods. Groups also did not differ in the proportion of neonates with serum Cr levels higher than the reference range (>0.4 mg/dL) at any time point (iodine- [P > .12] or gadolinium-based [P > .13] contrast material). Similar findings were observed for GFRs. None of the neonates developed nephrogenic systemic fibrosis. Conclusion In the absence of known renal failure, neonates receiving standard inpatient care do not appear to be at increased risk for developing renal toxicity due to administration of intravenous iodine- and gadolinium-based contrast material. © RSNA, 2017.
引用
- Bedoya MA, White AM, Edgar JC, et al. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates. Radiology. 2017. PMID: 28387639. doi:10.1148/radiol.2017160895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。